Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Urinary CD8+ T-cell counts discriminate between active and inactive lupus nephritis.

Dolff S, Abdulahad WH, Arends S, van Dijk MC, Limburg PC, Kallenberg CG, Bijl M.

Arthritis Res Ther. 2013 Feb 27;15(1):R36. doi: 10.1186/ar4189.

2.

Urinary T cells in active lupus nephritis show an effector memory phenotype.

Dolff S, Abdulahad WH, van Dijk MC, Limburg PC, Kallenberg CG, Bijl M.

Ann Rheum Dis. 2010 Nov;69(11):2034-41. doi: 10.1136/ard.2009.124636. Epub 2010 May 14.

PMID:
20472588
3.

Urine levels of HMGB1 in Systemic Lupus Erythematosus patients with and without renal manifestations.

Abdulahad DA, Westra J, Bijzet J, Dolff S, van Dijk MC, Limburg PC, Kallenberg CG, Bijl M.

Arthritis Res Ther. 2012 Aug 14;14(4):R184. doi: 10.1186/ar4015.

4.

Urinary CD4 T cells identify SLE patients with proliferative lupus nephritis and can be used to monitor treatment response.

Enghard P, Rieder C, Kopetschke K, Klocke JR, Undeutsch R, Biesen R, Dragun D, Gollasch M, Schneider U, Aupperle K, Humrich JY, Hiepe F, Backhaus M, Radbruch AH, Burmester GR, Riemekasten G.

Ann Rheum Dis. 2014 Jan;73(1):277-83. doi: 10.1136/annrheumdis-2012-202784. Epub 2013 Mar 8.

PMID:
23475982
5.

Mapping urinary chemokines in human lupus nephritis: Potentially redundant pathways recruit CD4+ and CD8+ T cells and macrophages.

Klocke J, Kopetschke K, Grießbach AS, Langhans V, Humrich JY, Biesen R, Dragun D, Radbruch A, Burmester GR, Riemekasten G, Enghard P.

Eur J Immunol. 2017 Jan;47(1):180-192. doi: 10.1002/eji.201646387. Epub 2016 Nov 21.

PMID:
27753073
6.

The cellular signature of urinary immune cells in Lupus nephritis: new insights into potential biomarkers.

Kopetschke K, Klocke J, Grießbach AS, Humrich JY, Biesen R, Dragun D, Burmester GR, Enghard P, Riemekasten G.

Arthritis Res Ther. 2015 Apr 3;17:94. doi: 10.1186/s13075-015-0600-y.

7.

Urinary FOXP3 mRNA in patients with lupus nephritis--relation with disease activity and treatment response.

Wang G, Lai FM, Tam LS, Li EK, Kwan BC, Chow KM, Li PK, Szeto CC.

Rheumatology (Oxford). 2009 Jul;48(7):755-60. doi: 10.1093/rheumatology/kep074. Epub 2009 May 20.

PMID:
19458162
8.

Increased urinary interleukin 22 binding protein levels correlate with lupus nephritis activity.

Yang X, Gao Y, Wang H, Zhao X, Gong X, Wang Q, Zhang X.

J Rheumatol. 2014 Sep;41(9):1793-800. doi: 10.3899/jrheum.131292. Epub 2014 Aug 1.

PMID:
25086075
9.

Estimation of kidney injury molecule-1 (Kim-1) in patients with lupus nephritis.

Nozaki Y, Kinoshita K, Yano T, Shiga T, Hino S, Niki K, Kishimoto K, Funauchi M, Matsumura I.

Lupus. 2014 Jul;23(8):769-77. doi: 10.1177/0961203314526292. Epub 2014 Mar 5.

PMID:
24598218
10.

[Urinary fibronectin as an indicator of kidney fibrosis in nephritis].

Kozlovskaia LV, Bobkova IN, Varshavskiĭ VA, Proskurneva EP, Miroshnichenko NG, Chebotareva NV, Mukhin NA.

Ter Arkh. 1999;71(6):34-8. Russian.

PMID:
10420453
11.

Changes of memory B- and T-cell subsets in lupus nephritis patients.

Kosalka J, Jakiela B, Musial J.

Folia Histochem Cytobiol. 2016;54(1):32-41. doi: 10.5603/FHC.a2016.0005. Epub 2016 Apr 20.

12.

Urinary proteomic profiles distinguish between active and inactive lupus nephritis.

Mosley K, Tam FW, Edwards RJ, Crozier J, Pusey CD, Lightstone L.

Rheumatology (Oxford). 2006 Dec;45(12):1497-504. Epub 2006 Oct 17.

PMID:
17046860
13.

Predominance of CD8+ T lymphocytes among periglomerular infiltrating cells and link to the prognosis of class III and class IV lupus nephritis.

Couzi L, Merville P, Deminière C, Moreau JF, Combe C, Pellegrin JL, Viallard JF, Blanco P.

Arthritis Rheum. 2007 Jul;56(7):2362-70.

14.

Urinary CXCL-10/IP-10 and MCP-1 as markers to assess activity of lupus nephritis.

Abujam B, Cheekatla S, Aggarwal A.

Lupus. 2013 May;22(6):614-23. doi: 10.1177/0961203313484977. Epub 2013 Apr 29.

PMID:
23629827
15.

Activity of childhood lupus nephritis is linked to altered T cell and cytokine homeostasis.

Edelbauer M, Kshirsagar S, Riedl M, Billing H, Tönshoff B, Haffner D, Cortina G, Amon O, Ross S, Dötsch J, Wechselberger G, Weber LT, Dablander M, Anliker M, Griesmacher A, Steichen-Gersdorf E.

J Clin Immunol. 2012 Jun;32(3):477-87. doi: 10.1007/s10875-011-9637-0. Epub 2012 Jan 8.

PMID:
22228566
16.

CXCR3+CD4+ T cells are enriched in inflamed kidneys and urine and provide a new biomarker for acute nephritis flares in systemic lupus erythematosus patients.

Enghard P, Humrich JY, Rudolph B, Rosenberger S, Biesen R, Kuhn A, Manz R, Hiepe F, Radbruch A, Burmester GR, Riemekasten G.

Arthritis Rheum. 2009 Jan;60(1):199-206. doi: 10.1002/art.24136.

17.

Estimation of monocyte-chemoattractantprotein-1 (Mcp-1) level in patients with lupus nephritis.

Alzawawy A, Zohary M, Ablordiny M, Eldalie M.

Int J Rheum Dis. 2009 Dec;12(4):311-8. doi: 10.1111/j.1756-185X.2009.01429.x.

PMID:
20374368
18.

Increased expression of costimulatory markers CD134 and CD80 on interleukin-17 producing T cells in patients with systemic lupus erythematosus.

Dolff S, Quandt D, Wilde B, Feldkamp T, Hua F, Cai X, Specker C, Kribben A, Kallenberg CG, Witzke O.

Arthritis Res Ther. 2010;12(4):R150. doi: 10.1186/ar3100. Epub 2010 Jul 23.

19.

Monocyte chemoattractant-1 as a urinary biomarker for the diagnosis of activity of lupus nephritis in Brazilian patients.

Rosa RF, Takei K, Araújo NC, Loduca SM, Szajubok JC, Chahade WH.

J Rheumatol. 2012 Oct;39(10):1948-54. doi: 10.3899/jrheum.110201. Epub 2012 Sep 1.

PMID:
22942263
20.

Urinary sCD25 as a biomarker of lupus nephritis disease activity.

Gupta R, Yadav A, Misra R, Aggarwal A.

Lupus. 2015 Mar;24(3):273-9. doi: 10.1177/0961203314555174. Epub 2014 Oct 10.

PMID:
25305215

Supplemental Content

Support Center